These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27536462)

  • 21. Iron in Restless Legs Syndrome.
    Schulte EC; Kaffe M; Schormair B; Winkelmann J
    Mov Disord Clin Pract; 2014 Sep; 1(3):161-172. PubMed ID: 30363981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping intrinsic functional brain changes and repetitive transcranial magnetic stimulation neuromodulation in idiopathic restless legs syndrome: a resting-state functional magnetic resonance imaging study.
    Liu C; Dai Z; Zhang R; Zhang M; Hou Y; Qi Z; Huang Z; Lin Y; Zhan S; He Y; Wang Y
    Sleep Med; 2015 Jun; 16(6):785-91. PubMed ID: 25959094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of BTBD9 in the Cerebellum, Sleep-like Behaviors and the Restless Legs Syndrome.
    Lyu S; Xing H; DeAndrade MP; Perez PD; Yokoi F; Febo M; Walters AS; Li Y
    Neuroscience; 2020 Aug; 440():85-96. PubMed ID: 32446853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain-iron deficiency models of restless legs syndrome.
    Earley CJ; Jones BC; Ferré S
    Exp Neurol; 2022 Oct; 356():114158. PubMed ID: 35779614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroanatomy and Functional Connectivity in Patients with Parkinson's Disease with or without Restless Legs Syndrome.
    Zang QL; Zheng JH; Ma JJ; Zhang Q; Huang PP; Shen NN; Miao W
    Neurol Ther; 2022 Dec; 11(4):1625-1636. PubMed ID: 35999489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neurophysiology of hyperarousal in restless legs syndrome: Hints for a role of glutamate/GABA.
    Lanza G; Ferri R
    Adv Pharmacol; 2019; 84():101-119. PubMed ID: 31229167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptible genes of restless legs syndrome in migraine.
    Fuh JL; Chung MY; Yao SC; Chen PK; Liao YC; Hsu CL; Wang PJ; Wang YF; Chen SP; Fann CS; Kao LS; Wang SJ
    Cephalalgia; 2016 Oct; 36(11):1028-1037. PubMed ID: 26643377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathophysiology of restless legs syndrome].
    Monaca C
    Presse Med; 2010 May; 39(5):587-91. PubMed ID: 20346613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of functional GLO1 variants in the BTBD9 locus and restless legs syndrome.
    Gan-Or Z; Zhou S; Ambalavanan A; Leblond CS; Xie P; Johnson A; Spiegelman D; Allen RP; Earley CJ; Desautels A; Montplaisir JY; Dion PA; Xiong L; Rouleau GA
    Sleep Med; 2015 Sep; 16(9):1151-5. PubMed ID: 26298793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding.
    Cervenka S; Pålhagen SE; Comley RA; Panagiotidis G; Cselényi Z; Matthews JC; Lai RY; Halldin C; Farde L
    Brain; 2006 Aug; 129(Pt 8):2017-28. PubMed ID: 16816393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A potential role for zinc in restless legs syndrome.
    Chen P; Bornhorst J; Patton S; Bagai K; Nitin R; Miah M; Hare DJ; Kysenius K; Crouch PJ; Xiong L; Rouleau GA; Schwerdtle T; Connor J; Aschner M; Bowman AB; Walters AS
    Sleep; 2021 Apr; 44(4):. PubMed ID: 33175142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insight into the pathophysiology of restless legs syndrome.
    Earley CJ; Allen RP; Beard JL; Connor JR
    J Neurosci Res; 2000 Dec; 62(5):623-8. PubMed ID: 11104500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report.
    Allen RP; Picchietti DL; Auerbach M; Cho YW; Connor JR; Earley CJ; Garcia-Borreguero D; Kotagal S; Manconi M; Ondo W; Ulfberg J; Winkelman JW;
    Sleep Med; 2018 Jan; 41():27-44. PubMed ID: 29425576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes of cortical excitability after dopaminergic treatment in restless legs syndrome.
    Scalise A; Pittaro-Cadore I; Janes F; Marinig R; Gigli GL
    Sleep Med; 2010 Jan; 11(1):75-81. PubMed ID: 19595629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restless legs syndrome: pathophysiology and modern management.
    Nagandla K; De S
    Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iron and restless legs syndrome: treatment, genetics and pathophysiology.
    Connor JR; Patton SM; Oexle K; Allen RP
    Sleep Med; 2017 Mar; 31():61-70. PubMed ID: 28057495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caenorhabditis elegans and its applicability to studies on restless legs syndrome.
    Chen P; Ijomone OM; Lee KH; Aschner M
    Adv Pharmacol; 2019; 84():147-174. PubMed ID: 31229169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of MEIS1 in restless legs syndrome: From GWAS to functional studies in mice.
    Salminen AV; Lam DD; Winkelmann J
    Adv Pharmacol; 2019; 84():175-184. PubMed ID: 31229170
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Sarayloo F; Dion PA; Rouleau GA
    Front Neurol; 2019; 10():935. PubMed ID: 31551905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional connectivity alternation of the thalamus in restless legs syndrome patients during the asymptomatic period: a resting-state connectivity study using functional magnetic resonance imaging.
    Ku J; Cho YW; Lee YS; Moon HJ; Chang H; Earley CJ; Allen RP
    Sleep Med; 2014 Mar; 15(3):289-94. PubMed ID: 24555993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.